论文部分内容阅读
N-(2-羟乙基)烟酰胺硝酸酯是新近向世的抗心绞痛药,商品名有硝烟酯、烟浪丁、SG-75,尼卡地尔(Nicorandil,以下简称NCR),于1975年由日本首先合成,1984年投放市场。国内徐州医学科学研究所同江苏丰县制药厂、济南神州制药厂协作研制的NCR,分别于1985年和1987年通过鉴定,与会专家认为本品悬一种颇有前途的抗心绞痛药,并建议尽快生
N- (2-hydroxyethyl) nicotinamide nitrate is a recent anti-anginal drug available under the trade names nicotinate, nicotine, SG-75, Nicorandil (NCR) Year first synthesized by Japan, put on the market in 1984. National Xuzhou Institute of Medical Sciences with Jiangsu Fengxian Pharmaceutical Factory, Jinan, China Pharmaceutical Co., collaboratively developed NCR, respectively, in 1985 and 1987 through the identification of experts believe that this product is a promising anti-anginal drug and recommended as soon as possible Health